Not every PRP‐gel is born equal Evaluation of growth factor availability for tissues through four PRP‐gel preparations: Fibrinet®, RegenPRP‐Kit®, Plateltex® and one manual procedure

Vox Sanguinis - Tập 97 Số 2 - Trang 110-118 - 2009
Laura Mazzucco1, Valeria Balbo1, Elena Cattana1, Roberto Guaschino1, P. Borzini1
1Centro Trasfusionale e Laboratorio Biotecnologie, Ospedale ‘SS Antonio e Biagio’, Alessandria, Italy

Tóm tắt

Background  The rationale for using topical platelet gel therapy is to provide the healing tissues with concentrated platelet‐derived factors. Several systems are available to prepare platelet‐rich plasma (PRP) and from these, the platelet gel. These systems produce two‐ to six‐fold platelet and growth factor‐enriched concentrations. The bioavailability of growth factors in tissue healing depends on the amount of growth factors stored in platelets but a portion of these is lost during platelet manipulation. Very few data have been reported on the kinetics of growth factor release from PRP‐gels. The aim of this study is to assess the growth factor recovery and its bioavailability to tissues in four different PRP and PRP‐gel preparation techniques.

Materials and methods  Three commercially available devices (Fibrinet®, RegenPRP‐Kit®, Plateltex®) and one manual procedure (home made, HM) were evaluated with reference to resulting platelet concentration, growth factor content and the kinetics of growth factor release from gel.

Results  Platelet concentration increased from 1·65‐ to 4·4‐fold in comparison with whole blood initially used. The final platelet concentration (× 103/µl) was: Fibrinet 1358 ± 419, Regen 430 ± 109, HM 1196 ± 188, and Plateltex 1160 ± 164. A high variation (5‐ to 27‐fold) was found in growth factor concentration in relation to the method used and also a high variation in the kinetics of growth factor release from gels.

Conclusions  Similar methods for platelet gel preparation revealed different performances concerning growth factor recovery and the kinetics of its release from the gel. It is unclear whether these noticeable differences are important for clinical management.

Từ khóa


Tài liệu tham khảo

Rosenthal AR, 1975, Use of a platelet‐fibrinogen‐thrombin mixture as a corneal adhesive: experiments with sutureless lamellar keratoplasty in the rabbit, Invest Ophthalmol, 14, 872

10.1097/00000658-198609000-00011

10.1016/j.bone.2003.12.010

Everts PA, 2006, Platelet‐rich plasma and platelet gel: a review, J Extra Corpor Technol, 38, 174, 10.1051/ject/200638174

10.1111/j.1537-2995.2005.00600.x

Weibrich G, 2005, Comparison of the platelet concentrate collection system with the plasma‐rich‐in‐growth‐factors kit to produce platelet‐rich plasma: a technical report, Int J Oral Maxillofac Impants, 20, 118

10.1182/blood.V70.1.307.307

10.1016/S0022-1759(97)00160-9

10.1038/bjc.1998.158

10.1111/j.1423-0410.2007.01027.x

10.1097/SAP.0b013e318157a185

10.1016/j.bone.2004.08.020

10.1002/term.119

Anitua E, 1999, Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants, Int J Oral Maxillofac Implants, 14, 529

10.1111/j.1537-2995.2008.01945.x

Smyth SS, 1993, Regulation of ligand binding to glycoprotein IIb‐IIIa (integrin alpha IIb beta 3) in isolated platelet membranes, Biochem J, 292, 749, 10.1042/bj2920749

10.1111/j.1537-2995.2008.01691.x

10.1097/01.PRS.0000138251.07040.51

10.1054/jcms.2002.0285

10.1016/j.tripleo.2005.07.009

10.1080/08977190802636713

10.1177/154405910508400507

10.1186/1477-7827-5-4

Stanojević G, 2004, The effects of topical fibrin glue and epidermal growth factor (EGF) on the colon anastomosis healing process: a comparative experimental study, Facta Universitatis: Med Biol, 11, 113

10.1038/sj.onc.1208560

10.1016/j.bone.2006.05.023

10.1172/JCI116563

10.1111/j.1651-2227.1991.tb17983.x

10.1111/j.1537-2995.2008.01862.x

10.1158/0008-5472.CAN-03-1916

10.1111/j.1365-2184.2007.00430.x

10.1016/j.joms.2004.09.012

10.1177/0363546508314430